Effects of a mouthwash with chlorine dioxide on oral malodor and salivary bacteria: A randomized placebo-controlled 7-day trial

Trials

Volumn 11, Issue , 2010, Pages

  Shinada, Kayoko ^a   Ueno, Masayuki ^a   Konishi, Chisato ^a   Takehara, Sachiko ^a   Yokoyama, Sayaka ^a   Zaitsu, Takashi ^a   Ohnuki, Mari ^a   Wright, Fredrick A C ^b   Kawaguchi, Yoko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b New South Wales Government   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINE DIOXIDE; DIMETHYL SULFIDE; HYDROGEN SULFIDE; METHANETHIOL; MOUTHWASH; PLACEBO; CHLORINE DERIVATIVE; OXIDE; SULFIDE; THIOL DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BACTERIAL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVENING DOSAGE; FUSOBACTERIUM NUCLEATUM; GAS CHROMATOGRAPHY; GINGIVA; HALITOSIS; HUMAN; MALE; MORNING DOSAGE; MOUTH FLORA; MOUTH HYGIENE; MOUTH PLAQUE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SENSORY SYSTEM PARAMETERS; TONGUE; TREATMENT DURATION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATIENT SATISFACTION; SALIVA; TIME; TREATMENT OUTCOME;

ADULT; ANTI-INFECTIVE AGENTS, LOCAL; CHLORINE COMPOUNDS; CHROMATOGRAPHY, GAS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FUSOBACTERIUM NUCLEATUM; HALITOSIS; HUMANS; HYDROGEN SULFIDE; MALE; MOUTHWASHES; ORAL HYGIENE; OXIDES; PATIENT SATISFACTION; SALIVA; SULFHYDRYL COMPOUNDS; SULFIDES; TIME FACTORS; TONGUE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949468387     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-14     Document Type: Article

References (56)

1. Krespi YP, Shrime MG, Kacker A. The relationship between oral malodor and volatile sulfur compound-producing bacteria. Otolaryngol Head Neck Surg 2006, 135:671-676. 10.1016/j.otohns.2005.09.036, 17071291.
2. Tonzetich J. Production and origin of oral malodor: a review of mechanisms and methods of analysis. J Periodontol 1977, 48:13-20.
3. Miyazaki H, Sakao S, Katoh Y, Takehara T. Correlation between volatile sulfur compounds and certain oral health measurements in the general population. J Periodontol 1995, 66:679-684.
4. Murata T, Yamaga T, Iida T, Miyazaki H, Yaegaki K. Classification and examination of halitosis. Int Dent J 2002, 52(Suppl 3):181-186.
5. Yaegaki K, Sanada K. Volatile sulfur compounds in mouth air from clinically healthy subjects and patients with periodontal disease. J Periodontal Res 1992, 27:233-238. 10.1111/j.1600-0765.1992.tb01673.x, 1640345.
6. Nakano Y, Yoshimura M, Koga T. Correlation between oral malodor and periodontal bacteria. Microbes Infect 2002, 4:679-683. 10.1016/S1286-4579(02)01586-1, 12048037.
7. Persson S, Edlund MB, Claesson R, Carlsson J. The formulation of hydrogen sulfide and methyl mercaptan by oral bacteria. Oral Microbiol Immunol 1990, 5:195-201. 10.1111/j.1399-302X.1990.tb00645.x, 2082242.
8. van Steenberghe D, Avontroodt P, Peeters W, Pauwels M, Coucke W, Lijnen A, Quirynen M. Effect of different mouthrinses on morning breath. J Periodontol 2001, 72:1183-1191. 10.1902/jop.2000.72.9.1183, 11577950.
9. Pianotti R, Lachette S, Dills S. Desulfuration of cysteine and methionine by Fusobacterium nucleatum. J Dent Res 1986, 65:913-917.
10. Loesche WJ, Kazor C. Microbiology and treatment of halitosis. Periodontol 2000 2002, 28:256-279. 10.1034/j.1600-0757.2002.280111.x, 12013345.
11. Roldán S, Winkel EG, Herrera D, Sanz M, van Winkelhoff AJ. The effects of a new mouthrinse containing chlorhexidine, cetylpyridium chloride and zinc lactate on the microflora of oral halitosis patients: a dual-centre, double-blind placebo-controlled study. J Clin Periodontol 2003, 30:427-434. 10.1034/j.1600-051X.2003.20004.x, 12716335.
12. Bosy A, Kulkarni GV, Rosenberg M, McCulloch G. Relationship of oral malodor to periodontitis: evidence of independence in discrete subpopulations. J Periodontol 1994, 65:37-46.
13. De Boever EH, Loesche WJ. Assessing the contribution of anaerobic microflora of the tongue to oral malodor. J A D A 1995, 126:1384-1393.
14. Gürgan CA, Zaim E, Bakirsoy I, Soykan E. Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse used as an adjunct to non-surgical periodontal treatment: a double-blind clinical study. J Periodontol 2006, 77:370-384. 10.1902/jop.2006.050141, 16512751.
15. Lorenz K, Bruhn G, Heumann C, Netuschil L, Brecx M, Hoffmann T. Effect of two new chlorhexidine mouthrinses on the development of dental plaque, gingivitis, and discolouration. A randomized, investigator-blind, placebo-controlled, 3-week experimental gingivitis study. J Clin Periodontol 2006, 33:561-567. 10.1111/j.1600-051X.2006.00946.x, 16899099.
16. Lynch E, Sheerin A, Claxson AWD, Atherton MD, Rhodes CJ, Silwood CJL, Naughton DP, Grootveld M. Multicomponent spectroscopic investigations of salivary antioxidant consumption by an oral rinse preparation containing the stable free radical species chlorine dioxide (ClO2). Free Radical Res 1997, 26:209-234.
17. Yates R, Moran J, Addy M, Mullan PJ, Wade WG, Newcombe R. The comparative effect of acidified sodium chlorite and chlorhexidine mouthrinses on plaque regrowth and salivary bacterial counts. J Clin Periodontol 1997, 24:603-609. 10.1111/j.1600-051X.1997.tb00236.x, 9378830.
18. Frascella J, Gilbert R, Fernandez P. Odor reduction potential of a chlorine dioxide mouthrinse. J Clin Dent 1998, 9:39-42.
19. Grootveld M, Silwood CJ, Gill D, Lynch E. Evidence for the microbicidal activity of a chlorine dioxide-containing oral rinse formulation in vivo. J Clin Dent 2001, 12:67-70.
20. Shinada K, Ueno M, Konishi C, Takehara S, Yokoyama S, Kawaguchi Y. A randomized, double blind, crossover, placebo-controlled clinical trial to assess the effects of a mouthwash containing chlorine dioxide on oral malodor. Trials 2008, 9:71. 10.1186/1745-6215-9-71, 2637235, 19068114.
21. Silwood CJ, Grootveld M, Lynch E. A multifactorial investigation of the ability of oral health care products (OHCPs) to alleviate oral malodour. J Clin Periodontol 2001, 28:634-641. 10.1034/j.1600-051x.2001.028007634.x, 11422584.
22. Frascella J, Gilbert RD, Fernandez P, Hendler J. Efficacy of a chlorine dioxide-containing mouthrinse in oral malodor. Comp Cont Educ Dent 2000, 21:241-248.
23. Quirynen M, Avontroodt P, Soers C, Zhao H, Pauwels M, Coucke W, van Steenberghe D. The efficacy of amine fluoride/stannous fluoride in the suppression of morning breath odour. J Clin Periodontol 2002, 29:944-954. 10.1034/j.1600-051X.2002.291010.x, 12445227.
24. Tonzetich J. Oral malodour: an indicator of health status and oral cleanliness. Int Dent J 1978, 28:309-319.
25. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963, 21:533-551. 10.3109/00016356309011240, 14121956.
26. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964, 22:121-135. 10.3109/00016356408993968, 14158464.
27. Winkel EG, Roldán S, van Winkelhoff AJ, Herrera D, Sanz M. The clinical effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc-lactate on oral halitosis. A dual-center, double-blind placebo-controlled study. J Clin Periodontol 2003, 30:300-306. 10.1034/j.1600-051X.2003.00342.x, 12694427.
28. Gomez SM, Danser MM, Sipos PM, Rowshani B, Welden U, Weijden GA. Tongue coating and salivary bacterial counts in healthy/gingivitis subjects and periodontal patients. J Clin Periodontol 2001, 28:970-978. 10.1034/j.1600-051x.2001.028010970.x, 11686816.
29. Tadokoro K, Yamaguchi T, Kawamura K, Shimizu H, Egashira T, Minabe M, Oguchi H. Rapid quantification of periodontitis-related bacteria using a novel modification of Invader PLUS technologies. Microbiological Research 2010, 165:43-49. 10.1016/j.micres.2008.06.001, 18718748.
30. Rosenberg M, McCulloch CA. Measurement of oral malodor: current methods and future prospects. J Periodontol 1992, 63:776-782.
31. Sopapornamorn P, Ueno M, Vachirarojpisan T, Shinada K, Kawaguchi Y. Association between oral malodor and measurements obtained using a new sulfide monitor. J Dent 2006, 34:770-774. 10.1016/j.jdent.2006.02.004, 16603305.
32. Sandham JA. The FDI two-digit system of designating teeth. Int Dent J 1983, 33:390-392.
33. Oho T, Yoshida Y, Shimazaki Y, Yamashita Y, Koga T. Characteristics of patients complaining of halitosis and the usefulness of gas chromatography for diagnosing halitosis. Oral Surg Oral Med Oral Pathol Oral Radio Endod 2001, 91:531-534.
34. Awano S, Gohara K, Kurihara E, Ansai T, Takehara T. The relationship between the presence of periodontopathogenic bacteria in saliva and halitosis. Int Dent J 2002, 52(Suppl 3):212-216.
35. Gornitsky M, Paradis I, Randaverde G, Malo AM, Velly AM. A clinical and microbiological evaluation of denture cleansers for geriatric patients in long-term care institutions. J Can Dent Assoc 2002, 68:39-45.
36. Mohammad AR, Giannini PJ, Preshaw PM, Alliger H. Clinical and microbiological efficacy of chlorine dioxide in the management of chronic atrophic candidiasis: an open study. Int Dent J 2004, 54:154-158.
37. Takayama M, Sugimoto H, Mizutani S, Tanno K. Bactericidal activities of chlorine dioxide. J Antibact Antifung Agents 1995, 23:401-406.
38. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996, 11:266-273. 10.1111/j.1399-302X.1996.tb00180.x, 9002880.
39. Tanaka M, Yamamoto Y, Kuboniwa M, Nonaka A, Nishida N, Maeda K, Kataoka K, Nagata H, Shizukuishi S. Contribution of periodontal pathogens on tongue dorsa analyzed with real-time PCR to oral malodor. Microbes Infect 2004, 6:1078-1083. 10.1016/j.micinf.2004.05.021, 15380777.
40. Bolstad AI, Jensen HB, Bakken V. Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clin Microbiol Rev 1996, 9:55-71. 172882, 8665477.
41. Sharma A, Inagaki S, Sigurdson W, Kuramitsu HK. Synergy between Tannerella forsythensis and Fusobacterium nucleatum in biofilm formation. Oral Microbiol Immunol 2005, 20:39-42. 10.1111/j.1399-302X.2004.00175.x, 15612944.
42. Bradshaw DI, Marsh PD, Watson GK, Allison C. Role of Fusobacterium nucleatum and coaggration in anaerobe survival in plantonic and biofilm oral microbial communities during aeration. Infect Immun 1998, 66:4729-4732. 108582, 9746571.
43. Roldán S, Herrera D, O'Connor A, Gonzalez I, Sanz M. A combined therapeutic approach to manage oral halitosis: A 3-month prospective case series. J periodontal 2005, 76:1025-1033.
44. Kurata H, Awano S, Yoshida A, Ansai T, Takehara T. The prevalence of periodontopathogenic bacteria in saliva is linked to periodontal health status and oral malodour. J Med Microbiol 2008, 57:636-642. 10.1099/jmm.0.47706-0, 18436598.
45. Hakuta C, Mori C, Ueno M, Shinada K, Kawaguchi Y. Evaluation of an oral function promotion program for the independent elderly in Japan. Gerodontol 2009, 26:250-258.
46. Roldán S, Herrera D, Santa-Cruz I, O'Connor A, Gonzalez I, Sanz M. Comparative effects of different chlorhexidine mouth-rinse formulations on volatile sulfur compound and salivary bacterial counts. J Clin Periodontol 2004, 31:1128-1134. 10.1111/j.1600-051X.2004.00621.x, 15560817.
47. Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol 2004, 31:878-884. 10.1111/j.1600-051X.2004.00578.x, 15367192.
48. Bolanowski SJ, Gescheider GA, Suttin SVW. Relationship between oral pain and ethanol concentration in mouthrinses. J Periodontal Res 1995, 30:192-197. 10.1111/j.1600-0765.1995.tb01273.x, 7473002.
49. Young A, Jonski G, Rölla G. Inhibition of orally produced volatile sulfur compounds by zinc, chlorhexidine or cetylpyridium chloride - effect of concentration. Eur J Oral Sci 2003, 111:400-404. 10.1034/j.1600-0722.2003.00063.x, 12974683.
50. Nogueira-Filho GR, Duarte PM, Toledo S, Tabchoury CP, Cury JA. Effect of triclosan dentifrices on mouth volatile sulfur compounds and dental plaque trypsin-like activity during experimental gingivitis development. J Clin Periodontol 2002, 29:1059-1064. 10.1034/j.1600-051X.2002.291202.x, 12492904.
51. Roldán S, Herrera D, Sanz M. Biofilms and the tongue: therapeutical approaches for the control of halitosis. Clin Oral Invest 2003, 7:189-197.
52. Food and Drug Administration FDA 21 CFR 173.325 (e). Acidified sodium chlorite solutions Food and Drug Administration., http://www.thefederalregister.com/d.p/2004-12-30-04-28577
53. Kimoto K, Hamada N, Ohno M, Furuya M, Kushida M, Usui S, Toda S, Kawamura K, Okudera H, Hirata Y, Umemoto T, Arakawa H. Study on the bactericidal effects of chlorine dioxide gas. Bull Kanagawa Dent College 2004, 32:77-82.
54. Suarez FL, Furne JK, Springfield J, Levitt MD. Morning breath odor: influence of treatments on sulfur gases. J Dent Res 2000, 79:1773-1777. 10.1177/00220345000790100701, 11077993.
55. Carvalho MD, Tabchoury CM, Cury JA, Toledo S, Nogueira-Filho GR. Impact of mouthrinses on morning bad breath in healthy subjects. J Clin Periodontol 2004, 31:85-90. 10.1111/j.0303-6979.2004.00452.x, 15016031.
56. Faveri M, Hayacibara MF, Pupio GC, Cury JA, Tsuzuki CO, Hayacibara RM. A cross-over study on the effect of various therapeutic approaches to morning breath odour. J Clin Periodontol 2006, 33:555-560. 10.1111/j.1600-051X.2006.00955.x, 16899098.